Monday, 15 June 2020

Personal Protective Equipment Market Latest Trend, Growth, Size, Application & Forecast 2026

According to a new study published by Polaris Market Research the Global personal protective equipment (PPE) market is anticipated to reach USD 81.35 billion by 2026. The market growth is propelled majorly by the increasing concerns of employers over the safety of its employees. Employers are highly responsible for offering a healthy and safe workplace to their workers. Employees working at industrial sites are prone to different forms for hazards, they are likely to come across sharp objects, flying sparks, unbearable loud noise, falling objects, and chemicals that could cause them serious injuries.


Companies especially those belonging to industrial, manufacturing, and construction sectors have realized that it is better to take precautions and prevent any lethal damage to any of their workers. Many regulatory bodies have laid guidelines to promote the safety and health of workforce. For instance, Occupational Safety and Health Administration (OSHA) in the U.S. is responsible for formulating standards that are aimed to encourage a safe and healthy environment for employees. OSHA has set requirements for the use of PPE such as 29 CFR 1910.135 (Head protection); 29 CFR 1910.137 (Electrical protective equipment); 29 CFR1910.136 (Foot protection), and29 CFR 1910.138 (Hand protection), among others. OSHA together with few other agencies such as National Institute for Occupational Safety and Health (NIOSH), and National Fire Protection Association (NFPA), among others standardizes guidelines for work environment.

Major players operating in the market includes companies such as MSA Safety Inc., Ansell Ltd., 3M Company, Alpha Pro. Tech Ltd., Rock Fall Ltd.,JSP Ltd., Oftenrich Holdings Co. Ltd, JAL Group, COFRA Holding AG, Golden Chang, Avon Rubber p. i. c., Rahman Group, and Honeywell International Inc., among others.


PPE finds application in various industries including oil & gas, petrochemicals, transportation, food& beverages, power & energy, construction, and healthcare, among others. Among these industries, construction industry is experiencing highest application, and is among one of the largest end-use industry that is driving the market. The industry is flourishing in Asia Pacific region, primarily due to the presence of developing nations that are heavily investing in their infrastructural facilities.


Key Findings from the study suggest that the largest share of the market in 2017 was of the North American region. Moreover, the market is segmented on the basis of products and end use. On the basis of product, the market can be segmented into eye protection, hand protection, head protection, hearing protection, fall protection, protective clothing, professional footwear, and respiratory protection, among other. Professional footwear is anticipated to foresee highest growth, owing to their wide range of application across various industries. These footwears are largely utilized for protection from sharp edge objects, and helps avoid direct contact from any hazardous chemicals.


About Polaris Market Research
We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us
Polaris Market Research
Phone: 1–646–568–9980
on No comments:
Labels: , , ,

Blood Glucose Monitoring Device Market 2026 Future Forecast Indicates Impressive Growth Rate

The Blood Glucose Monitoring Device market is anticipated to reach over USD 2.61 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the orthopedic treatment dominated the global Blood Glucose Monitoring Device market, in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global market revenue in 2017.

The increasing need for home care diagnosis and real time data by the end users to primarily drive the blood glucose monitoring device market during the forecast period. These devices have potential market due to the rising technology advancements in this industry during the forecast period. Moreover, the major supporting factor for this market growth is the number of populations suffering from diabetes. According to the World Health Organization (WHO), approximately there were direct deaths if 1.6 million in 2015, and this number is attributed to rise by 2030 making diabetes the 7th leading cause of death globally.


Furthermore, the changing life style of the people, and rising preference to the sedentary life style to also support the market growth in the coming years. However, lack of awareness, limited use of these devices, and no proper reimbursements regulation by the government would impede the market growth during the forecast period. 

North America generated the highest revenue in the Blood Glucose Monitoring Device market in 2017, and is expected to be the leading region globally during the forecast period. Increasing demand, rising patient awareness for proper self-diagnosis methods, which saves the time, money, and provides accurate real-time data about the patient health. Also, decreasing cost & time of treatment, and continuous research and development in the same field to also boost the market growth in coming years. While, Asia Pacific blood glucose monitoring device market  is supposed to the fastest growing market during forecast period.

Do you have questions or special requirements? Ask our industry Experts: https://www.polarismarketresearch.com/industry-analysis/blood-glucose-monitoring-device-market/speak-to-analyst

The key players operating in the Blood Glucose Monitoring Device market include Abbott Laboratories, Terumo Corporation, ARKRAY Inc., Medtronic Plc., Acon Laboratories Inc., Roche Diagnostics Ltd., Johnson & Johnson, Novo Nordisk A/S, Becton, Dickinson and Co., Sanofi, Bayer AG, Ypsomed AG. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

About Polaris Market Research
We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us
Polaris Market Research
Phone: 1–646–568–9980




on No comments:
Labels: , ,

Regenerative Medicines Market Incredible Possibilities, Growth Analysis And Forecast To 2026

The Regenerative Medicine Market is anticipated to reach over USD 79.23 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the cell therapy dominated the global Regenerative Medicine market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue in 2017.

Regenerative medicine is a branch of medicine that regrows, and repairs the damaged cells in the human body. These medicines include the use of stem cells, tissue engineering, that further helps in developing new organ that function smoothly. These medicines have the caliber of developing an entire organ as these cells are multipotent. The cells are majorly isolated from bone marrow, and umbilical cord blood.


The regenerative medicine market is primarily driven by the increasing number of individuals suffering from cancer, rising need to monitor and treating these chronic diseases in the limited time. Furthermore, stringent government policies, proper reimbursement policies, and increasing government healthcare expenditure for developing healthcare infrastructure to also boost the market growth in coming years. Also, rising number of organ transplantation, and increasing number of products in pipeline that are waiting for approval create major opportunity for the regenerative medicines in the coming years. However, some of the ethical and religious concerns for the use of stem cells, and lack of proper regulatory for the approval of various drugs would impede the market growth during the forecast period.

North America generated the highest revenue in the Regenerative Medicine market in 2017, and is expected to be the leading region globally during the forecast period. Increasing number of patients suffering from chronic diseases, improved healthcare infrastructure and health facilities, accessibility of healthcare facilities, are the primary factors driving the market growth in this region. While, Asia Pacific to be the fastest growing region in the coming years. The growth in this region is majorly attributed to the developing healthcare infrastructure of the countries like India, & China, and rising awareness for the use of regenerative medicines as an effective treatment option for chronic diseases.

Do you have questions or special requirements? Ask our industry experts : https://www.polarismarketresearch.com/industry-analysis/regenerative-medicine-market/speak-to-analyst

The key players operating in the Regenerative Medicine market include Organogenesis Inc., Vericel Corporation, Osiris Therapeutics, Inc., Stryker Corporation, and NuVasive, Inc., Medtronic Plc., Acelity, Cook Biotech Inc., Integra LifeSciences, and C.R. Bard. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

About Polaris Market Research
We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us
Polaris Market Research
Phone: 1–646–568–9980
on No comments:
Labels: , , , ,

Flexible Packaging Market Global Demand, Industry Growth,In-Depth Analysis And Opportunities Till 2026

The global Flexible Packaging Market is anticipated to reach $335 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the food and beverage segment accounted for the highest market share in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global Flexible Packaging market revenue in 2017.

The increasing disposable incomes and growing demand for fast moving consumer goods drives the growth of the flexible packaging market. Growing urbanization has resulted in urban citizens spending most of their time at work and everyday commute, which has increased the demand for convenient packaging for on-the-go consumption, thereby supporting the flexible packaging market growth. Brand owners are taking initiatives to optimize packaging operations to meet the global competition, increase productivity, enhance shelf life of products, improve overall efficiency, and create brand differentiation in the market. The demand for new and unique packaging sizes, shapes and configurations has increased from industries such as food and beverages, cosmetics, and healthcare among others. The increasing need to offer convenient packaging solutions while also addressing environmental concerns has boosted the flexible packaging market growth.


Numerous key players have adopted partnership and acquisition strategies to increase their market share in the global flexible packaging market. For instance, In December 2015, Mondi Group signed an agreement for the acquisition of 95% of the outstanding share capital in KSP, Co. KSP is a flexible packaging company based in South Korea with strong focus on production of high-quality spouted and retort stand-up pouches for food, pet food and beverage industries. The acquisition of KSP compliments Mondi’s stand-up pouch operations in Korneuburg, Austria and Jackson, US while expanding its presence in U.S. and Asia. In July 2016, Mondi Group also signed an agreement to acquire Uralplastic. Uralplastic manufactures a range of consumer flexible packaging products for food, hygiene, homecare and other applications. The acquisition of Uralplastic supports the development of Mondi’s consumer packaging business, strengthens its presence in the Russian consumer packaging market, and expands its offerings in the flexible packaging market.

Asia-Pacific generated the highest market share in terms of revenue in 2018 in the flexible packaging industry, and is expected to lead the global Flexible Packaging market throughout the forecast period. The growing population, rising disposable incomes, and increasing living standards support the growth of flexible packaging industry in the region. The increasing demand from the food and beverage, and retail industry is expected to generate numerous opportunities for the Flexible Packaging industry.

Do you have questions or special requirements? Ask our industry experts @ https://www.polarismarketresearch.com/industry-analysis/flexible-packaging-market/speak-to-analyst

The well-known companies profiled in the Flexible Packaging report include Amcor Limited, Mondi Group, Berry Plastics Corporation, Sonoco Products Company, American Packaging Corporation, Novolex Holding Inc., Bemis Company, Inc, Constantia Flexibles International GmbH, Ampac Holding, and Sigma Plastics Group. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

About Polaris Market Research
We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us
Polaris Market Research
Phone: 1–646–568–9980


on No comments:
Labels: , , ,

Thursday, 11 June 2020

US Telemedicine Market Share and Demand-Analysis of Key Players- Research Forecasts to 2026

The global U.S. Telemedicine Market size is expected to reach USD 17.14 Billion by 2026 according to a new study by Polaris Market Research. The report “U.S. Telemedicine Market Share, Size, Trends, Industry Analysis Report By Component (Hardware, Software & Services); By Application (Teleradiology, Telepsychiatry, Telestroke, Tele-ICU, Teledermatology, Teleconsultation); Mode of Delivery (Mobile Health Apps, Virtual, Telemedicine Portals & kiosks, Others); By End User; Segment Forecast, 2020 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The U.S. Telemedicine Market is projected to witness a significant growth over the forecast period. Rising need to maintain social distance due to corona pandemic, focus on expanding healthcare facilities and give easy access to the public, overall of shortage of physicians, advancement in telecommunication technologies, and growing government support are some of the factors benefitting the U.S. Telemedicine medicine market. High utility of Telemedicine in treating diseases and conditions especially in rural areas is benefitting the market growth in the country.

U.S. is characterized by strong support and initiatives taken by government to boost Telemedicine market. In the recent past, the U.S. government took concrete steps by boosting Telemedicine sector to overcome medical challenges and emergencies faced by the country. The American Telemedicine Association (ATA), during the opioid epidemic, took concentrated efforts to boost Telemedicine usage in the country. These moves were aimed at fully utilizing the advantages of Telemedicine to give wider healthcare accessibility.



Large companies are collaborating with cloud service providers to gain enhanced Telemedicine capabilities and to increase their market shares. They are providing services such as assessment and monitoring, education, preventive measures, diagnosis, among others. These are done by combining various elements such as digital imaging, telecommunications, video-conferencing, etc. Advancements in each of these aspects is particularly benefitting the U.S. Telemedicine medicine market.

The rapid adoption of cloud in the overall Telemedicine market in the U.S. has resulted in successfully offsetting up of difficulties related to travel, physical storage of files, access issues and need of patient & doctor to be in the same place. Recent developments in privacy and security and high awareness pertaining to it among the U.S. population have resulted in the development of encryption techniques that allow more secure data, adoption of authentication measures at each step and access of data without violating patient privacy. All these factors are benefitting the Telemedicine market in the country.

Healthcare innovation and rising prominence of virtualization are some of the key industry trends. Market participants are concentrating on strengthening their overall service lines and are also facilitating the provision of customized solutions to their patients through the use of technology. Protected health information security, cost and operational efficiency, on -demand, easy access whenever and wherever patients demand, are some of the critical success factors observed in the U.S. market. The market is bound to grow as more and more healthcare service operators are turning to Telemedicine to manage the influx of patients into their facilities.

Some of the leading players in the U.S. Telemedicine market include Koninklijke Philips, Medtronic, GE Healthcare, Cerner Corporation, Siemens Healthineers AG, Cisco Systems, Asahi Kasei Corporation, Iron Bow Technologies, American Well, Teladoc Health, Medvivo Group, AMC Health, Chiron Health, Zipnosis, VSEE, IMEDIPLUS, MEDWEB, U.S.MED. among others

Do you have questions or special requirements? Ask our industry experts : https://www.polarismarketresearch.com/industry-analysis/us-telemedicine-market/speak-to-analyst

Polaris Market research has segmented the U.S. Telemedicine Market report on the basis of component, application, mode of delivery, end-use, and mode of prescription
U.S. Telemedicine Component Outlook (Revenue, USD Million, 2015 – 2026)
  • Hardware
    • Telemedicine Carts
    • Kiosks
    • Digital Cameras
    • Telemedicine Kits
    • Mobile Medical Devices
    • Other Devices
  • Software & Services
    • Remote Patient Monitoring Software & Services
    • Real-Time Interaction Software & Services
    • Store-And-Forward Software & Services
U.S. Telemedicine Application Outlook (Revenue, USD Million, 2015 – 2026)
  • Teleradiology
  • Telepsychiatry
  • Telestroke
  • Tele-ICU
  • Teledermatology
  • Teleconsultation
  • Other Applications
U.S. Telemedicine Mode of Delivery Outlook (Revenue, USD Million, 2015 – 2026)
  • Mobile Health Apps
  • Virtual
  • Telemedicine Portals & kiosks
  • Others
U.S. Telemedicine End User Outlook (Revenue, USD Million, 2015 – 2026)
  • Providers
  • Payers
  • Patients
  • Others


on No comments:
Labels: , ,

Vitamin K2 Market Factors Helping to Maintain Strong Position Globally 2020-2026

The report “Vitamin K2 Market Share, Size, Trends, Industry Analysis Report By Product (MK-4, and MK-7), By Application (Pharmaceuticals, Nutraceuticals & Food, Others); By Source (Natural, Synthetic, Others); By Regions, Segment Forecast, 2020 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth. The global Vitamin K2 market size is expected to reach USD 290.3 million by 2026 according to a new study by Polaris Market Research.
The alarming cases of vitamin deficiency in humans are anticipated to be a primary trigger for demand in the global market. A study conducted by the Food & Agriculture Organization of United Nations (FAO) in the year 2018 revealed that vitamin K deficiency bleeding (VKDB) in infants has emerged to be a major concern for infant mortality. Such incidences are anticipated to be the primary demand generators over the forecast period.

Osteoporosis is another major ailment which constraints growth of new tissues in the human body. More than 38 million people globally suffered of osteoporosis between 2017-18, as per Osteoporosis Foundation statistics. Hence, compensation of calcium deficiency in the human body is expected to be the main area of vitamin K2 consumption. Multifunctional ingredients ensure extended shelf life of foods, and significantly improve the texture and taste of the end-products, hence these ingredients have become a rage in the pharmaceutical industry. The ageing as well as geriatric population creates a bigger room for manufacturers in terms of product innovation.



As far as the production/derivation methods of vitamin K2 are concerned, natural source accounts for a higher share in the market followed by synthetic means. Production method of the ingredient is a crucial concern particularly in the pharmaceutical industry, as manufacturers have to keenly assess the drug testing criteria put forth by governing authorities. The pharmaceuticals and food application segment is expected to consume the highest amount of vitamin K2 as a result of changing lifestyles, health awareness, and rising disposable income of people. Powders and oils are the primary forms through which vitamin K2 would be integrated in foods.

As of 2019, North America holds the largest market share followed by Europe and Asia Pacific. A drastic increase in the consumption of functional foods by the citizens of Australia, China, and India are likely to speed up the demand of vitamin K2 in Asia Pacific over the next five years. Middle East and Africa is likely to pose a moderate demand for vitamin K2 because of the already existing health and wellness campaigns deployed by the government.

Do you have questions or special requirements? Ask our industry experts : https://www.polarismarketresearch.com/industry-analysis/vitamin-k2-market/speak-to-analyst

Mergers & acquisitions (M&A), collaborations, partnerships, capacity expansion plans, heavy amount of research & development, and signing long term distribution contracts with local sales giants are the key strategies adhered by market participants to maintain and strengthen their position in the global landscape.

The key players in the market include Danisco A/S (DuPont Health and Nutrition), Kappa Bioscience, DSM, BASF, Gnosis SpA, Frutarom, NattoPharma, Seebio Biotech, and Geneferm Biotechnology Co. Ltd. among others. Direct selling proves to be a cost-effective channel for SMEs to gain customer trust.

Polaris Market research has segmented the vitamin K2 market report on the basis of product, application, source and region

Vitamin K2 Product Outlook (Revenue, USD Million, 2015 – 2026)
  • MK-4
  • MK-7
  • Others
Vitamin K2 Application Outlook (Revenue, USD Million, 2015 – 2026)
  • Pharmaceutical
  • Nutraceuticals & Food
  • Others
Vitamin K2 Source Outlook (Revenue, USD Million, 2015 – 2026)
  • Natural
  • Synthetic


Contact us : 
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.comWeb: www.polarismarketresearch.com
on No comments:
Labels: , , , ,

Fitness App Market Global Demand, Industry Growth,In-depth Analysis and Opportunities till 2026

The Global fitness app market size is anticipated to reach over USD 15.96 billion by 2026, according to a new study published by Polaris Market Research. In 2019, the fitness and activity tracking segment dominated the market, in terms of revenue. North America is expected to be the leading contributor to the global fitness app industry during the forecast period.

A significant increase in the obese population, changing lifestyles, and increasing health concerns primarily drive the market growth.  Other driving factors include increasing occurrence of diseases associated with obesity, increasing disposable income, and increasing awareness regarding health and nutrition. The increase in obesity related diseases such as diabetes and hypertension along with sedentary lifestyles of consumers further propel the market growth. The number of memberships for health clubs and gyms has increased significantly over the years, further promoting the growth of fitness app industry. Increasing demand in developing nations, increasing penetration of mobile devices, and availability of high-speed internet services is expected provide numerous growth opportunities to the fitness app industry players during the forecast period.


A few major fitness apps available in the market include Runtastic Results, Calorie Counter & Diet Tracker, and Sweat, Kayla Itsines Fitness among others. Runtastic Results: Workout & Strength Training is offered by the Austrian company Runtastic. As part of the primary marketing strategy in fitness app industry, the company offers a wide range of portfolio with 20 different mobile apps running on all platforms. Runtastic was bought by Adidas in 2015 to increase its market share in the global fitness market industry. Sweat: Kayla Itsines Fitness is an app offered by The Bikini Body Training Company. This app provides nutrition recommendations and a series of aerobic exercises in the Bikini Body Guide (BBG) to practice at home.

In regards with the global fitness app market share, North America was in the forefront followed by Asia Pacific and Europe. The increasing population in the region coupled with high disposable income drives the market growth. The sedentary lifestyle of consumers in the region has encouraged them to adopt fitness apps to stay healthy and acquire proper nutrition. Asia-Pacific is expected to grow at the highest rate during the forecast period. Increasing disposable incomes in developing countries of this region, rising awareness and increasing health consciousness, growing presence of fitness centres, and growing penetration of smartphones further foster the growth of the fitness app industry in this region.

Do you have questions or special requirements? Ask our industry experts : https://www.polarismarketresearch.com/industry-analysis/fitness-app-market/speak-to-analyst


The key companies profiled in the report fitness app market analysis includes MyFitnessPal Inc., Dom and Tom Tom, Motorola Mobility LLC, Grandapps, Fitbit, Azumio, WillowTree, Inc., ASICS, Under Armour, and Appster among others. These companies launch new products and collaborate with other market leaders bringing innovation to meet the increasing demand of consumers.

Polaris Market Research has segmented the global fitness app market on the basis of type, platform, deployment, gender, and region:

 Fitness App Type Outlook (Revenue, USD Billion, 2015 – 2026) 
  • Workout & Exercise Apps
  • Disease Management
  • Lifestyle Management
  • Nutrition & Diet
  • Medication Adherence
Fitness App Platform Outlook (Revenue, USD Billion, 2015 – 2026)
  • Smartphones
  • Tablets
  • Wearable Devices
Fitness App Deployment Outlook (Revenue, USD Billion, 2015 – 2026)
  • Android
  • iOS
  • Windows
  • Others


Contact us : 
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.comWeb: www.polarismarketresearch.com
on No comments:
Labels: , , ,

Sunglasses Market In Depth Industry Analysis on Trends, Growth, Opportunities and Forecast till 2026

The global Sunglasses market size is expected to reach USD 27.72 billion by 2026 according to a new study by Polaris Market Research. The report “Sunglasses Market Share, Size, Trends, Industry Analysis Report By Product (Polarized, Non-Polarized), By Material (CR-39, Polycarbonate, Polyurethane, Others), By Channel (Online, Offline), By Regions, Segments & Forecast, 2020 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Demand for sunglasses has led to the need for reduced dependency on spectacles and uptake of contact lenses. Therefore, growing awareness among the general population regarding the importance of protecting the eyes is the key driving force for the market. Sunglasses exhibit the highest growth rate, which is a direct result of burgeoning prices, especially in the high-end segment of the market. The expected increase in the demand of sunglasses for health, lifestyle, and cosmetic purposes is also expected to drive the market.

Companies such as Luxottica Group S.p.A., Prada SPA, Safilo Group S.p.A, Fielmann AG, De Rigo SpA, Kering SA, Capri Holdings, LVMH, Marcolin S.p.A, and Maui Jim are some of the key players operating in the market.


The average selling price of sunglasses is expected to be highest in the Europe, which is expected to drive the revenue in this market. Due to the dominant presence of major players of the market in Europe, there exists higher brand awareness and thus higher demand for the high-end sunglasses sector. This can be attributed to increasing awareness regarding eye healthcare and a trendsetting consumer base backed by abundant disposable incomes.
  
Increasing purchasing power backed by rising disposable incomes among the consumers across various regional markets is expected to drive the demand for sunglasses across the global market. Growing income level and households in the middle class have led to increased aggregate disposable income in developing regions.

Additionally, the proliferation of the internet and online retailing services is expected to positively impact the market. The Japanese market is characterized by growing demand for online purchase of sunglasses. However, growth in internet retailing has resulted in low product prices and thus has adversely affected the revenue streams. Growing purchase volumes of sunglasses are expected to curb the impact of this trend over the next seven years. High scope for penetration in this sector is expected to be an opportunity for industry participants.

Do you have questions or special requirements? Ask our industry experts: https://www.polarismarketresearch.com/industry-analysis/sunglasses-market/speak-to-analyst

Independent retailers and stores are businesses under private ownerships. These are usually single-store operations and offer both high risks and high rewards for the store owner. Major sunglasses vendors and brands give away franchising rights to individuals or enterprises willing to open up independent stores for a specific brand, retailer, or vendor for a certain royalty or franchise fee to be given to the sunglasses manufacturer.

Manufacturers have also made available prescription eyewear and sunglasses across several regions to grow their customer base. However, there lies a strong belief among consumers that sunglasses sold at certain drugstores are not customized and not in accordance with the prescription, due to which they do not focus the images but rather make them appear larger, thus costing significantly lesser.


Contact us
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , , , ,

Myasthenia Gravis Disease Market Trends, Latest Innovations, Drivers, Dynamics And Strategic Analysis, Challenges

The new report  Global Myasthenia Gravis Disease Market is estimated to reach USD 2,538.6 million by 2026 from USD 1,012.2 million in 2017. The market is anticipated to grow at a CAGR of 10.8% during the forecast period.
Myasthenia gravis disease is a neuromuscular ailment that causes the weakness of skeletal muscles, that are used for body movement. MG Disease is generally caused by an autoimmune disease when communication between muscles and nerve cells becomes impaired. According to the Myasthenia Gravis Foundation of America, MG is relatively rare condition that affects approximately 14 to 20 out of every 100,000 people in the United States. Moreover, according to the National Institutes of Health (NIH), MG typically occurs in people over the age of 40 where Women are more likely to be diagnosed as younger adults. There is no exact cure for the MG disease. However, through appropriate diagnosis and medication treatment, the disease can be controlled over the time. The symptoms of the MG disease include facial paralysis, difficulty breathing due to muscle weakness, difficulty swallowing or chewing, drooping of eyelids, and trouble in walking.
The global Myasthenia Gravis Disease market is majorly driven by the factor such as high incidences of neuromuscular disorders. Moreover, increasing number of clinical facilities across the region and rising consciousness about the treatment are other factors driving the market growth. However, the unfamiliarity with early symptoms as well as signs and high cost associated with the treatment are factors hampering the market growth.
Segment Analysis:
  • Myasthenia Gravis Disease Market By Disease Type (Imaging (X-ray, Computed Tomography, Magnetic Resonance Imaging) Blood Tests, Electrodiagnostic, and Edrophonium Test);
  • Myasthenia Gravis Disease Market By Treatment (Medication, Surgery, HSCT);
  • Myasthenia Gravis Disease Market By End-User (Hospitals, Clinics, Academic Research Institutes) ;
  • Myasthenia Gravis Disease Market By Region North America [U.S., Canada], Europe [Germany, UK, France, Italy, Spain, Belgium, Netherlands, Rest of Europe], Asia-Pacific [China, India, Japan, South Korea, Singapore, Malaysia, Rest of Asia-Pacific], Latin America [ Brazil, Mexico, Argentina, Rest of Latin America], Middle East and Africa [Israel, South Africa, Saudi Arabia, UAE, Rest of MEA]
  •  
The report provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the Global Myasthenia Gravis Disease Market, 2017-2026. This report comprises a detailed geographic distribution of the market across North America, Europe, APAC, Latin America, and MEA. North America is further segmented into U.S., Canada, and Mexico. Europe is divided into Germany, UK, Italy, France, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, and Rest of Asia-Pacific. In 2017, North America Myasthenia Gravis Disease Market was estimated to dominate the market growth due to high occurrence of disease such in North America.
Competitive Landscape and Key Vendors
The leading companies profiled in the Myasthenia Gravis Disease Market report include Alexion Pharmaceutical Inc., Avadel Pharmaceuticals plc, CSL Behring, Grifols S.A., Baxter International Inc., Shire plc, Novartis AG, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, and Valeant Pharmaceuticals International Inc.
Geographically, North America accounted for the largest share in the global Myasthenia Gravis Disease Market in 2017. The major factors accounted for the high market growth includes high occurrence of disease such in North America. Moreover, Asia Pacific is estimated to generate the lucrative market growth during the forecast period. Growing initiatives by government and private organizations for generating novel control treatment are factors estimated to propel the myasthenia gravis disease market growth in Asia Pacific. In addition, increasing awareness about neuromuscular disorders and vast improvement are boosting the market growth in APAC.
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact us
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.comWeb: www.polarismarketresearch.com
on No comments:
Labels: , , ,
Subscribe to: Posts (Atom)